Article
DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma.
Free radical research - 1 Mar 2011
Cabello Christopher M, Lamore Sarah D, Bair Warner B, Davis Angela L, Azimian Sara M, Wondrak Georg T
Abstract excerpt
Accumulative experimental evidence suggests feasibility of chemotherapeutic intervention targeting human cancer cells by pharmacological modulation of cellular oxidative stress. Current efforts aim at personalization of redox chemotherapy through identification of predictive tumour genotypes and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
